GammaStack is Excited to Attend ICE Barcelona 2025
15.1.2025 10:00:00 CET | ACCESS Newswire | Press release
GammaStack is delighted to showcase its innovative software solutions at ICE Barcelona 2025 from 20-22 January at Fira Barcelona Gran Via, booth 2B36. Join them to connect, collaborate and explore new opportunities!
BARCELONA, ES / ACCESSWIRE / January 15, 2025 / GammaStack is thrilled to announce their participation in ICE Barcelona 2025 from 20th to 22nd January at Fira Barcelona Gran Via. GammaStack is stationed at booth number 2B36.GammaStack is Excited to Attend ICE Barcelona 2025
GammaStack is Excited to Attend ICE Barcelona 2025
GammaStack, a recognized leader in the software and game development industry, is committed to driving innovation and staying ahead by addressing clients' challenges. Recently, GammaStack has enhanced its offerings with custom software development and exciting game development services. The team provides fully tailored solutions, including customization in UI/UX design, game selection, themes, bonus engines, API integrations, and more - all with no hidden fees.
Bespoke Software Solution Development
GammaStack is offering highly customizable/bespoke feature-loaded solutions that offer cross-platform compatibility, multi-currency support, multilingual platform, multiple games integration, API integrations, payment gateways of choice and more! GammaStack also offers post launch services that allow their customers to get additional support through marketing assistance, updates installation, 24/7 customer support and more.
GammaStack is also known for their comprehensive and advanced white label and turnkey software solutions that offer unlimited opportunities for customizations and also support 3rd party integrations.
Game Development Services
A whopping list of enticing games are included in GammaStack's game development services strengthening their portfolio. Enthralling games are developed through a chain of processes involving ideation, moodboard creation, high-quality graphics, out-of-the box audio-visual effects, myriad of themes choice and integrations. The games offer immersive experiences, allowing their customers to enhance player engagement.
"We are super-excited to be a part of ICE Barcelona 2025 and we are looking forward to meeting industry leaders, creating long-term connections and exchanging great ideas that will empower innovation.
We proudly endorse our bespoke software solutions and game development services. Our focus is on tailored, high-quality solutions that align technology and creativity to match our clients' unique business goals. We aim to help our customers by bringing their vision to life and cater to their unique requirements while helping them generate measurable results." says Arturs Zagurilo, CCO of GammaStack, Latvia.
About GammaStack
GammaStack has successfully established itself as a pioneer in the top-notch, feature-rich software and game development services. With over 13 years of software development market exposure, GammaStack boasts an expert team of 500+ professionals. Having technologically-upgraded well-versed professionals, GammaStack offers a large suite of software solutions with choosable tech stack and game development services globally. Additionally, hassle-free staff augmentation is made available for round-the-clock support and maintenance.
Book a meeting at sales@gammastack.com
Know more at https://www.gammastack.com/
Contact Information
Arturs Zagurilo
Chief Commercial Officer
sales@gammastack.com
+1 302 231 1373
Visit: https://www.gammastack.com/
SOURCE: GammaStack
View the original press release on accesswire.com
GammaStack
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom